Table of Content

1 Study Coverage
1.1 Antiallergics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Antiallergics Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Epinephrine
1.2.5 Allergen Immunotherapy
1.2.6 Decongestants
1.2.7 Others
1.3 Market by Application
1.3.1 Global Antiallergics Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antiallergics Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Antiallergics Drugs Revenue by Region
2.2.1 Global Antiallergics Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Antiallergics Drugs Revenue by Region (2018-2024)
2.2.3 Global Antiallergics Drugs Revenue by Region (2024-2029)
2.2.4 Global Antiallergics Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Antiallergics Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Antiallergics Drugs Sales by Region
2.4.1 Global Antiallergics Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Antiallergics Drugs Sales by Region (2018-2024)
2.4.3 Global Antiallergics Drugs Sales by Region (2024-2029)
2.4.4 Global Antiallergics Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Antiallergics Drugs Sales by Manufacturers
3.1.1 Global Antiallergics Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Antiallergics Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiallergics Drugs in 2022
3.2 Global Antiallergics Drugs Revenue by Manufacturers
3.2.1 Global Antiallergics Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Antiallergics Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antiallergics Drugs Revenue in 2022
3.3 Global Key Players of Antiallergics Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Antiallergics Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antiallergics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antiallergics Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antiallergics Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Antiallergics Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antiallergics Drugs Sales by Type
4.1.1 Global Antiallergics Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Antiallergics Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Antiallergics Drugs Sales Market Share by Type (2018-2029)
4.2 Global Antiallergics Drugs Revenue by Type
4.2.1 Global Antiallergics Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Antiallergics Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Antiallergics Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Antiallergics Drugs Price by Type
4.3.1 Global Antiallergics Drugs Price by Type (2018-2024)
4.3.2 Global Antiallergics Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Antiallergics Drugs Sales by Application
5.1.1 Global Antiallergics Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Antiallergics Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Antiallergics Drugs Sales Market Share by Application (2018-2029)
5.2 Global Antiallergics Drugs Revenue by Application
5.2.1 Global Antiallergics Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Antiallergics Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Antiallergics Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Antiallergics Drugs Price by Application
5.3.1 Global Antiallergics Drugs Price by Application (2018-2024)
5.3.2 Global Antiallergics Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Antiallergics Drugs Market Size by Type
6.1.1 US & Canada Antiallergics Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Antiallergics Drugs Revenue by Type (2018-2029)
6.2 US & Canada Antiallergics Drugs Market Size by Application
6.2.1 US & Canada Antiallergics Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Antiallergics Drugs Revenue by Application (2018-2029)
6.3 US & Canada Antiallergics Drugs Market Size by Country
6.3.1 US & Canada Antiallergics Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Antiallergics Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Antiallergics Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Antiallergics Drugs Market Size by Type
7.1.1 Europe Antiallergics Drugs Sales by Type (2018-2029)
7.1.2 Europe Antiallergics Drugs Revenue by Type (2018-2029)
7.2 Europe Antiallergics Drugs Market Size by Application
7.2.1 Europe Antiallergics Drugs Sales by Application (2018-2029)
7.2.2 Europe Antiallergics Drugs Revenue by Application (2018-2029)
7.3 Europe Antiallergics Drugs Market Size by Country
7.3.1 Europe Antiallergics Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Antiallergics Drugs Sales by Country (2018-2029)
7.3.3 Europe Antiallergics Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Antiallergics Drugs Market Size
8.1.1 China Antiallergics Drugs Sales (2018-2029)
8.1.2 China Antiallergics Drugs Revenue (2018-2029)
8.2 China Antiallergics Drugs Market Size by Application
8.2.1 China Antiallergics Drugs Sales by Application (2018-2029)
8.2.2 China Antiallergics Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Antiallergics Drugs Market Size by Type
9.1.1 Asia Antiallergics Drugs Sales by Type (2018-2029)
9.1.2 Asia Antiallergics Drugs Revenue by Type (2018-2029)
9.2 Asia Antiallergics Drugs Market Size by Application
9.2.1 Asia Antiallergics Drugs Sales by Application (2018-2029)
9.2.2 Asia Antiallergics Drugs Revenue by Application (2018-2029)
9.3 Asia Antiallergics Drugs Sales by Region
9.3.1 Asia Antiallergics Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Antiallergics Drugs Revenue by Region (2018-2029)
9.3.3 Asia Antiallergics Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antiallergics Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Antiallergics Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Antiallergics Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Antiallergics Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Antiallergics Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Antiallergics Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Antiallergics Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Antiallergics Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Antiallergics Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Antiallergics Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Akorn
11.1.1 Akorn Company Information
11.1.2 Akorn Overview
11.1.3 Akorn Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Akorn Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Akorn Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 GSK plc
11.3.1 GSK plc Company Information
11.3.2 GSK plc Overview
11.3.3 GSK plc Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GSK plc Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK plc Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Overview
11.4.3 Novartis AG Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis AG Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis AG Recent Developments
11.5 Mylan N.V.
11.5.1 Mylan N.V. Company Information
11.5.2 Mylan N.V. Overview
11.5.3 Mylan N.V. Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Mylan N.V. Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan N.V. Recent Developments
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Information
11.6.2 Teva Pharmaceutical Industries Overview
11.6.3 Teva Pharmaceutical Industries Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Teva Pharmaceutical Industries Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Industries Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Sanofi Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Boehringer Ingelheim International GmbH
11.8.1 Boehringer Ingelheim International GmbH Company Information
11.8.2 Boehringer Ingelheim International GmbH Overview
11.8.3 Boehringer Ingelheim International GmbH Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Boehringer Ingelheim International GmbH Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Boehringer Ingelheim International GmbH Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 AstraZeneca Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 Johnson & Johnson Private
11.10.1 Johnson & Johnson Private Company Information
11.10.2 Johnson & Johnson Private Overview
11.10.3 Johnson & Johnson Private Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Johnson & Johnson Private Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Johnson & Johnson Private Recent Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Overview
11.11.3 Bayer AG Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Bayer AG Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bayer AG Recent Developments
11.12 Merck & Co.
11.12.1 Merck & Co. Company Information
11.12.2 Merck & Co. Overview
11.12.3 Merck & Co. Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Merck & Co. Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck & Co. Recent Developments
11.13 Prestige Consumer Healthcare
11.13.1 Prestige Consumer Healthcare Company Information
11.13.2 Prestige Consumer Healthcare Overview
11.13.3 Prestige Consumer Healthcare Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Prestige Consumer Healthcare Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Prestige Consumer Healthcare Recent Developments
11.14 F. Hoffmann-La Roche
11.14.1 F. Hoffmann-La Roche Company Information
11.14.2 F. Hoffmann-La Roche Overview
11.14.3 F. Hoffmann-La Roche Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 F. Hoffmann-La Roche Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 F. Hoffmann-La Roche Recent Developments
11.15 Bristol-Myers Squibb Company
11.15.1 Bristol-Myers Squibb Company Company Information
11.15.2 Bristol-Myers Squibb Company Overview
11.15.3 Bristol-Myers Squibb Company Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Bristol-Myers Squibb Company Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Bristol-Myers Squibb Company Recent Developments
11.16 Almirall
11.16.1 Almirall Company Information
11.16.2 Almirall Overview
11.16.3 Almirall Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Almirall Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Almirall Recent Developments
11.17 Zenomed Healthcare Private
11.17.1 Zenomed Healthcare Private Company Information
11.17.2 Zenomed Healthcare Private Overview
11.17.3 Zenomed Healthcare Private Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Zenomed Healthcare Private Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Zenomed Healthcare Private Recent Developments
11.18 Cadila Pharmaceuticals
11.18.1 Cadila Pharmaceuticals Company Information
11.18.2 Cadila Pharmaceuticals Overview
11.18.3 Cadila Pharmaceuticals Antiallergics Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Cadila Pharmaceuticals Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Cadila Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antiallergics Drugs Industry Chain Analysis
12.2 Antiallergics Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiallergics Drugs Production Mode & Process
12.4 Antiallergics Drugs Sales and Marketing
12.4.1 Antiallergics Drugs Sales Channels
12.4.2 Antiallergics Drugs Distributors
12.5 Antiallergics Drugs Customers
13 Market Dynamics
13.1 Antiallergics Drugs Industry Trends
13.2 Antiallergics Drugs Market Drivers
13.3 Antiallergics Drugs Market Challenges
13.4 Antiallergics Drugs Market Restraints
14 Key Findings in The Global Antiallergics Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antiallergics Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Antihistamines
Table 3. Major Manufacturers of Corticosteroids
Table 4. Major Manufacturers of Epinephrine
Table 5. Major Manufacturers of Allergen Immunotherapy
Table 6. Major Manufacturers of Decongestants
Table 7. Major Manufacturers of Others
Table 8. Global Antiallergics Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Antiallergics Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Antiallergics Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Antiallergics Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Antiallergics Drugs Revenue Market Share by Region (2018-2024)
Table 13. Global Antiallergics Drugs Revenue Market Share by Region (2024-2029)
Table 14. Global Antiallergics Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Antiallergics Drugs Sales by Region (2018-2024) & (K Units)
Table 16. Global Antiallergics Drugs Sales by Region (2024-2029) & (K Units)
Table 17. Global Antiallergics Drugs Sales Market Share by Region (2018-2024)
Table 18. Global Antiallergics Drugs Sales Market Share by Region (2024-2029)
Table 19. Global Antiallergics Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 20. Global Antiallergics Drugs Sales Share by Manufacturers (2018-2024)
Table 21. Global Antiallergics Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Antiallergics Drugs Revenue Share by Manufacturers (2018-2024)
Table 23. Global Key Players of Antiallergics Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 24. Antiallergics Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 25. Global Antiallergics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Antiallergics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiallergics Drugs as of 2022)
Table 27. Global Key Manufacturers of Antiallergics Drugs, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Antiallergics Drugs, Product Offered and Application
Table 29. Global Key Manufacturers of Antiallergics Drugs, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Antiallergics Drugs Sales by Type (2018-2024) & (K Units)
Table 32. Global Antiallergics Drugs Sales by Type (2024-2029) & (K Units)
Table 33. Global Antiallergics Drugs Sales Share by Type (2018-2024)
Table 34. Global Antiallergics Drugs Sales Share by Type (2024-2029)
Table 35. Global Antiallergics Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Antiallergics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Antiallergics Drugs Revenue Share by Type (2018-2024)
Table 38. Global Antiallergics Drugs Revenue Share by Type (2024-2029)
Table 39. Antiallergics Drugs Price by Type (2018-2024) & (US$/Unit)
Table 40. Global Antiallergics Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 41. Global Antiallergics Drugs Sales by Application (2018-2024) & (K Units)
Table 42. Global Antiallergics Drugs Sales by Application (2024-2029) & (K Units)
Table 43. Global Antiallergics Drugs Sales Share by Application (2018-2024)
Table 44. Global Antiallergics Drugs Sales Share by Application (2024-2029)
Table 45. Global Antiallergics Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Antiallergics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Antiallergics Drugs Revenue Share by Application (2018-2024)
Table 48. Global Antiallergics Drugs Revenue Share by Application (2024-2029)
Table 49. Antiallergics Drugs Price by Application (2018-2024) & (US$/Unit)
Table 50. Global Antiallergics Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 51. US & Canada Antiallergics Drugs Sales by Type (2018-2024) & (K Units)
Table 52. US & Canada Antiallergics Drugs Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Antiallergics Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 54. US & Canada Antiallergics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Antiallergics Drugs Sales by Application (2018-2024) & (K Units)
Table 56. US & Canada Antiallergics Drugs Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Antiallergics Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 58. US & Canada Antiallergics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Antiallergics Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Antiallergics Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 61. US & Canada Antiallergics Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Antiallergics Drugs Sales by Country (2018-2024) & (K Units)
Table 63. US & Canada Antiallergics Drugs Sales by Country (2024-2029) & (K Units)
Table 64. Europe Antiallergics Drugs Sales by Type (2018-2024) & (K Units)
Table 65. Europe Antiallergics Drugs Sales by Type (2024-2029) & (K Units)
Table 66. Europe Antiallergics Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Antiallergics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Antiallergics Drugs Sales by Application (2018-2024) & (K Units)
Table 69. Europe Antiallergics Drugs Sales by Application (2024-2029) & (K Units)
Table 70. Europe Antiallergics Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Antiallergics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Antiallergics Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Antiallergics Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Antiallergics Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Antiallergics Drugs Sales by Country (2018-2024) & (K Units)
Table 76. Europe Antiallergics Drugs Sales by Country (2024-2029) & (K Units)
Table 77. China Antiallergics Drugs Sales by Type (2018-2024) & (K Units)
Table 78. China Antiallergics Drugs Sales by Type (2024-2029) & (K Units)
Table 79. China Antiallergics Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 80. China Antiallergics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Antiallergics Drugs Sales by Application (2018-2024) & (K Units)
Table 82. China Antiallergics Drugs Sales by Application (2024-2029) & (K Units)
Table 83. China Antiallergics Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 84. China Antiallergics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Antiallergics Drugs Sales by Type (2018-2024) & (K Units)
Table 86. Asia Antiallergics Drugs Sales by Type (2024-2029) & (K Units)
Table 87. Asia Antiallergics Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 88. Asia Antiallergics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Antiallergics Drugs Sales by Application (2018-2024) & (K Units)
Table 90. Asia Antiallergics Drugs Sales by Application (2024-2029) & (K Units)
Table 91. Asia Antiallergics Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 92. Asia Antiallergics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Antiallergics Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Antiallergics Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 95. Asia Antiallergics Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Antiallergics Drugs Sales by Region (2018-2024) & (K Units)
Table 97. Asia Antiallergics Drugs Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Antiallergics Drugs Sales by Type (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Antiallergics Drugs Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Antiallergics Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Antiallergics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Antiallergics Drugs Sales by Application (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Antiallergics Drugs Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Antiallergics Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Antiallergics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Antiallergics Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Antiallergics Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Antiallergics Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Antiallergics Drugs Sales by Country (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Antiallergics Drugs Sales by Country (2024-2029) & (K Units)
Table 111. Akorn Company Information
Table 112. Akorn Description and Major Businesses
Table 113. Akorn Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 114. Akorn Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Akorn Recent Developments
Table 116. Pfizer Company Information
Table 117. Pfizer Description and Major Businesses
Table 118. Pfizer Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 119. Pfizer Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Pfizer Recent Developments
Table 121. GSK plc Company Information
Table 122. GSK plc Description and Major Businesses
Table 123. GSK plc Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 124. GSK plc Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. GSK plc Recent Developments
Table 126. Novartis AG Company Information
Table 127. Novartis AG Description and Major Businesses
Table 128. Novartis AG Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 129. Novartis AG Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Novartis AG Recent Developments
Table 131. Mylan N.V. Company Information
Table 132. Mylan N.V. Description and Major Businesses
Table 133. Mylan N.V. Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 134. Mylan N.V. Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Mylan N.V. Recent Developments
Table 136. Teva Pharmaceutical Industries Company Information
Table 137. Teva Pharmaceutical Industries Description and Major Businesses
Table 138. Teva Pharmaceutical Industries Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 139. Teva Pharmaceutical Industries Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Teva Pharmaceutical Industries Recent Developments
Table 141. Sanofi Company Information
Table 142. Sanofi Description and Major Businesses
Table 143. Sanofi Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 144. Sanofi Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Sanofi Recent Developments
Table 146. Boehringer Ingelheim International GmbH Company Information
Table 147. Boehringer Ingelheim International GmbH Description and Major Businesses
Table 148. Boehringer Ingelheim International GmbH Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 149. Boehringer Ingelheim International GmbH Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Boehringer Ingelheim International GmbH Recent Developments
Table 151. AstraZeneca Company Information
Table 152. AstraZeneca Description and Major Businesses
Table 153. AstraZeneca Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 154. AstraZeneca Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. AstraZeneca Recent Developments
Table 156. Johnson & Johnson Private Company Information
Table 157. Johnson & Johnson Private Description and Major Businesses
Table 158. Johnson & Johnson Private Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 159. Johnson & Johnson Private Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Johnson & Johnson Private Recent Developments
Table 161. Bayer AG Company Information
Table 162. Bayer AG Description and Major Businesses
Table 163. Bayer AG Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 164. Bayer AG Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Bayer AG Recent Developments
Table 166. Merck & Co. Company Information
Table 167. Merck & Co. Description and Major Businesses
Table 168. Merck & Co. Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 169. Merck & Co. Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Merck & Co. Recent Developments
Table 171. Prestige Consumer Healthcare Company Information
Table 172. Prestige Consumer Healthcare Description and Major Businesses
Table 173. Prestige Consumer Healthcare Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 174. Prestige Consumer Healthcare Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Prestige Consumer Healthcare Recent Developments
Table 176. F. Hoffmann-La Roche Company Information
Table 177. F. Hoffmann-La Roche Description and Major Businesses
Table 178. F. Hoffmann-La Roche Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 179. F. Hoffmann-La Roche Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. F. Hoffmann-La Roche Recent Developments
Table 181. Bristol-Myers Squibb Company Company Information
Table 182. Bristol-Myers Squibb Company Description and Major Businesses
Table 183. Bristol-Myers Squibb Company Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 184. Bristol-Myers Squibb Company Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Bristol-Myers Squibb Company Recent Developments
Table 186. Almirall Company Information
Table 187. Almirall Description and Major Businesses
Table 188. Almirall Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 189. Almirall Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 190. Almirall Recent Developments
Table 191. Zenomed Healthcare Private Company Information
Table 192. Zenomed Healthcare Private Description and Major Businesses
Table 193. Zenomed Healthcare Private Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 194. Zenomed Healthcare Private Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 195. Zenomed Healthcare Private Recent Developments
Table 196. Cadila Pharmaceuticals Company Information
Table 197. Cadila Pharmaceuticals Description and Major Businesses
Table 198. Cadila Pharmaceuticals Antiallergics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 199. Cadila Pharmaceuticals Antiallergics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 200. Cadila Pharmaceuticals Recent Developments
Table 201. Key Raw Materials Lists
Table 202. Raw Materials Key Suppliers Lists
Table 203. Antiallergics Drugs Distributors List
Table 204. Antiallergics Drugs Customers List
Table 205. Antiallergics Drugs Market Trends
Table 206. Antiallergics Drugs Market Drivers
Table 207. Antiallergics Drugs Market Challenges
Table 208. Antiallergics Drugs Market Restraints
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiallergics Drugs Product Picture
Figure 2. Global Antiallergics Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antiallergics Drugs Market Share by Type in 2022 & 2029
Figure 4. Antihistamines Product Picture
Figure 5. Corticosteroids Product Picture
Figure 6. Epinephrine Product Picture
Figure 7. Allergen Immunotherapy Product Picture
Figure 8. Decongestants Product Picture
Figure 9. Others Product Picture
Figure 10. Global Antiallergics Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Antiallergics Drugs Market Share by Application in 2022 & 2029
Figure 12. Hospital Pharmacy
Figure 13. Retail Pharmacy
Figure 14. Online Pharmacy
Figure 15. Antiallergics Drugs Report Years Considered
Figure 16. Global Antiallergics Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Antiallergics Drugs Revenue 2018-2029 (US$ Million)
Figure 18. Global Antiallergics Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Antiallergics Drugs Revenue Market Share by Region (2018-2029)
Figure 20. Global Antiallergics Drugs Sales 2018-2029 ((K Units)
Figure 21. Global Antiallergics Drugs Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Antiallergics Drugs Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Antiallergics Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Antiallergics Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Antiallergics Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Antiallergics Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. China Antiallergics Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Antiallergics Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Antiallergics Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Antiallergics Drugs Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Antiallergics Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Antiallergics Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Antiallergics Drugs in the World: Market Share by Antiallergics Drugs Revenue in 2022
Figure 34. Global Antiallergics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Antiallergics Drugs Sales Market Share by Type (2018-2029)
Figure 36. Global Antiallergics Drugs Revenue Market Share by Type (2018-2029)
Figure 37. Global Antiallergics Drugs Sales Market Share by Application (2018-2029)
Figure 38. Global Antiallergics Drugs Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Antiallergics Drugs Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Antiallergics Drugs Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Antiallergics Drugs Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Antiallergics Drugs Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Antiallergics Drugs Revenue Share by Country (2018-2029)
Figure 44. US & Canada Antiallergics Drugs Sales Share by Country (2018-2029)
Figure 45. U.S. Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Antiallergics Drugs Sales Market Share by Type (2018-2029)
Figure 48. Europe Antiallergics Drugs Revenue Market Share by Type (2018-2029)
Figure 49. Europe Antiallergics Drugs Sales Market Share by Application (2018-2029)
Figure 50. Europe Antiallergics Drugs Revenue Market Share by Application (2018-2029)
Figure 51. Europe Antiallergics Drugs Revenue Share by Country (2018-2029)
Figure 52. Europe Antiallergics Drugs Sales Share by Country (2018-2029)
Figure 53. Germany Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. France Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. China Antiallergics Drugs Sales Market Share by Type (2018-2029)
Figure 59. China Antiallergics Drugs Revenue Market Share by Type (2018-2029)
Figure 60. China Antiallergics Drugs Sales Market Share by Application (2018-2029)
Figure 61. China Antiallergics Drugs Revenue Market Share by Application (2018-2029)
Figure 62. Asia Antiallergics Drugs Sales Market Share by Type (2018-2029)
Figure 63. Asia Antiallergics Drugs Revenue Market Share by Type (2018-2029)
Figure 64. Asia Antiallergics Drugs Sales Market Share by Application (2018-2029)
Figure 65. Asia Antiallergics Drugs Revenue Market Share by Application (2018-2029)
Figure 66. Asia Antiallergics Drugs Revenue Share by Region (2018-2029)
Figure 67. Asia Antiallergics Drugs Sales Share by Region (2018-2029)
Figure 68. Japan Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. India Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Antiallergics Drugs Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Antiallergics Drugs Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Antiallergics Drugs Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Antiallergics Drugs Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Antiallergics Drugs Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Antiallergics Drugs Sales Share by Country (2018-2029)
Figure 79. Brazil Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Israel Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 83. GCC Countries Antiallergics Drugs Revenue (2018-2029) & (US$ Million)
Figure 84. Antiallergics Drugs Value Chain
Figure 85. Antiallergics Drugs Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed